Literature DB >> 2963053

The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders.

W Maier1, R Buller, M Philipp, I Heuser.   

Abstract

The Hamilton Anxiety Scale (HAM-A) was tested for reliability and validity in two different samples, one sample (n = 97) defined by anxiety disorders, the other sample (n = 101) defined by depressive disorders. The reliability and the concurrent validity of the HAM-A and its subscales proved to be sufficient. Internal validity tested by latent structure analysis was insufficient. The major problems with the HAM-A are that (1) anxiolytic and antidepressant effects cannot be clearly distinguished; (2) the subscale of somatic anxiety is strongly related to somatic side effects. The applicability of the HAM-A in anxiolytic treatment studies is therefore limited. More specific anxiety scales are needed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2963053     DOI: 10.1016/0165-0327(88)90072-9

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  220 in total

1.  Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.

Authors:  Christina R Di Iorio; Tristan J Watkins; Mary S Dietrich; Aize Cao; Jennifer U Blackford; Baxter Rogers; Mohammed S Ansari; Ronald M Baldwin; Rui Li; Robert M Kessler; Ronald M Salomon; Margaret Benningfield; Ronald L Cowan
Journal:  Arch Gen Psychiatry       Date:  2011-12-05

2.  Diagnostic comorbidity in adults with generalized anxiety disorder: impact of comorbidity on psychotherapy outcome and impact of psychotherapy on comorbid diagnoses.

Authors:  Michelle G Newman; Amy Przeworski; Aaron J Fisher; Thomas D Borkovec
Journal:  Behav Ther       Date:  2009-06-08

3.  Benign paroxysmal positional vertigo and post-treatment quality of life.

Authors:  Giuseppe Magliulo; Serena Bertin; Marzia Ruggieri; Mario Gagliardi
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-01-22       Impact factor: 2.503

4.  Maternal prenatal stress phenotypes associate with fetal neurodevelopment and birth outcomes.

Authors:  Kate Walsh; Clare A McCormack; Rachel Webster; Anita Pinto; Seonjoo Lee; Tianshu Feng; H Sloan Krakovsky; Sinclaire M O'Grady; Benjamin Tycko; Frances A Champagne; Elizabeth A Werner; Grace Liu; Catherine Monk
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-14       Impact factor: 11.205

Review 5.  The use of psychosocial stress scales in preterm birth research.

Authors:  Melissa J Chen; William A Grobman; Jackie K Gollan; Ann E B Borders
Journal:  Am J Obstet Gynecol       Date:  2011-08-04       Impact factor: 8.661

6.  A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder.

Authors:  Y Lecrubier; A J Puech; A Azcona; P E Bailey; X Lataste
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine. A double blind placebo controlled study.

Authors:  I M van Vliet; H G Westenberg; J A Den Boer
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Comparison of Electroacupuncture and Mild-Warm Moxibustion on Brain-Gut Function in Patients with Constipation-Predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.

Authors:  Ji-Meng Zhao; Jin-Hua Lu; Xiao-Jun Yin; Lu-Yi Wu; Chun-Hui Bao; Xing-Kui Chen; Yue-Hua Chen; Wei-Jun Tang; Xiao-Ming Jin; Huan-Gan Wu; Yin Shi
Journal:  Chin J Integr Med       Date:  2018-05-11       Impact factor: 1.978

Review 9.  A Critical Comprehensive Review of Religiosity and Anxiety Disorders in Adults.

Authors:  Dany R Khalaf; Ludger F Hebborn; Sylvain J Dal; Wadih J Naja
Journal:  J Relig Health       Date:  2015-08

10.  Mapping the effect of escitalopram treatment on amplitude of low-frequency fluctuations in patients with depression: a resting-state fMRI study.

Authors:  Li Wang; Xueni Li; Ke Li; Yunai Su; Yawei Zeng; Qinge Zhang; Gang Wang; Zhen Jin; Qingmei Kong; Tianmei Si
Journal:  Metab Brain Dis       Date:  2016-08-15       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.